ES8706028A1 - Pharmaceutical combinations with a synergistic action - Google Patents
Pharmaceutical combinations with a synergistic actionInfo
- Publication number
- ES8706028A1 ES8706028A1 ES542611A ES542611A ES8706028A1 ES 8706028 A1 ES8706028 A1 ES 8706028A1 ES 542611 A ES542611 A ES 542611A ES 542611 A ES542611 A ES 542611A ES 8706028 A1 ES8706028 A1 ES 8706028A1
- Authority
- ES
- Spain
- Prior art keywords
- synergistic action
- pharmaceutical combinations
- oxytetracycline
- tetracycline
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000002195 synergetic effect Effects 0.000 title abstract 2
- 239000004100 Oxytetracycline Substances 0.000 abstract 2
- 239000004098 Tetracycline Substances 0.000 abstract 2
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 abstract 2
- 229960000625 oxytetracycline Drugs 0.000 abstract 2
- 235000019366 oxytetracycline Nutrition 0.000 abstract 2
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 abstract 2
- 229960002180 tetracycline Drugs 0.000 abstract 2
- 235000019364 tetracycline Nutrition 0.000 abstract 2
- 229930101283 tetracycline Natural products 0.000 abstract 2
- 150000003522 tetracyclines Chemical class 0.000 abstract 2
- 239000004606 Fillers/Extenders Substances 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 210000004392 genitalia Anatomy 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention relates to pharmaceutical combinations with a synergistic action for the treatment of infections of the respiratory organs, of the gastrointestinal tract and of the urinary and genital organs of domestic animals with a content of 5-(hydroxy)tetracycline [oxytetracycline], where appropriate together with one or more conventional inert, non-toxic, solid and/or liquid pharmaceutical excipients, extenders and/or ancillary substance(s), which, apart from a) 5-(hydroxy)tetracycline [oxytetracycline] contain b) one or more antimicrobial organic acid(s) and/or water-soluble derivative(s) thereof, where appropriate with a) and b) being spacially separate from one another in one and the same pack or administration unit, where the a):b) ratio by weight is 0.5:10 to 10:0.5.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU841682A HU190963B (en) | 1984-04-28 | 1984-04-28 | Process for production of synergyc medical preparatives containing organic acids with oxitetracylin and antimicrobatic influence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8706028A1 true ES8706028A1 (en) | 1987-06-01 |
| ES542611A0 ES542611A0 (en) | 1987-06-01 |
Family
ID=10955662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES542611A Expired ES8706028A1 (en) | 1984-04-28 | 1985-04-26 | Pharmaceutical combinations with a synergistic action |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE902251A (en) |
| CH (1) | CH666817A5 (en) |
| DE (1) | DE3515214A1 (en) |
| ES (1) | ES8706028A1 (en) |
| FR (1) | FR2563433B1 (en) |
| HU (1) | HU190963B (en) |
| IT (1) | IT1200460B (en) |
| NL (1) | NL8501198A (en) |
| SE (1) | SE467445B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU200917B (en) * | 1987-07-20 | 1990-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical compositions comprising quinoline or naphthyridinecarboxylic acid and tetracycline derivatives as active ingredient |
| EP0951902A1 (en) * | 1998-03-31 | 1999-10-27 | Edmund J.H. Campion | A feed mixture |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH642850A5 (en) * | 1978-10-20 | 1984-05-15 | Ausonia Farma Srl | PHARMACEUTICAL COMPOSITIONS WITH ANTIBACTERIAL ACTIVITY AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE GERM INFECTIONS. |
-
1984
- 1984-04-28 HU HU841682A patent/HU190963B/en not_active IP Right Cessation
-
1985
- 1985-04-22 BE BE1/011244A patent/BE902251A/en not_active IP Right Cessation
- 1985-04-24 CH CH1750/85A patent/CH666817A5/en not_active IP Right Cessation
- 1985-04-26 IT IT20514/85A patent/IT1200460B/en active
- 1985-04-26 NL NL8501198A patent/NL8501198A/en not_active Application Discontinuation
- 1985-04-26 SE SE8502039A patent/SE467445B/en not_active IP Right Cessation
- 1985-04-26 FR FR8506395A patent/FR2563433B1/en not_active Expired
- 1985-04-26 DE DE19853515214 patent/DE3515214A1/en not_active Withdrawn
- 1985-04-26 ES ES542611A patent/ES8706028A1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CH666817A5 (en) | 1988-08-31 |
| IT8520514A0 (en) | 1985-04-26 |
| HU190963B (en) | 1986-12-28 |
| IT1200460B (en) | 1989-01-18 |
| SE467445B (en) | 1992-07-20 |
| HUT37349A (en) | 1985-12-28 |
| FR2563433A1 (en) | 1985-10-31 |
| BE902251A (en) | 1985-10-22 |
| ES542611A0 (en) | 1987-06-01 |
| FR2563433B1 (en) | 1988-12-02 |
| SE8502039D0 (en) | 1985-04-26 |
| DE3515214A1 (en) | 1985-10-31 |
| SE8502039L (en) | 1985-10-29 |
| NL8501198A (en) | 1985-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG42869A1 (en) | Pelletised pharmaceutical composition | |
| AU1358695A (en) | Nasal administration | |
| SG115193G (en) | Use of gamma-linolenic acid and related compounds for the manufacture of a medicament for the treatment of complications of diabetes mellitus | |
| US20180028560A1 (en) | Selenium-containing compositions and uses thereof | |
| WO1996024370B1 (en) | Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin | |
| AU4786396A (en) | Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin | |
| CA2038744A1 (en) | Pharmaceutical composition containing slightly water-soluble drug | |
| PL327323A1 (en) | Orally administered 5-asa containing pharmaceutic composition of modified active substance release and method of treating intestinal diseases | |
| GB2089660A (en) | Cobalt compound-containing preparations for arthritis treatment | |
| ES8706028A1 (en) | Pharmaceutical combinations with a synergistic action | |
| WO1996030016A3 (en) | Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases | |
| US20040023892A1 (en) | Pharmaceutical composition based on a non-steroid anti-inflammatory agent | |
| SU692604A1 (en) | Preparation for treating salmonollosis, collibacillosis, gastroenterocolitis of microbe etiology | |
| EP0753309A2 (en) | Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases | |
| SU1029451A1 (en) | Antibacterial composition | |
| DE2340515C3 (en) | Orally applicable preparation for the treatment of mycobacteriosis leprosy and tuberculosis | |
| Maezawa et al. | Clinical Investigations of Infections Associated With Cancer Chemotherapy. | |
| Fujimoto et al. | Chemotherapeutic efficacy of ofloxacin on renal and subcutaneous infection models with Staphylococcus aureus in mice | |
| RU2251414C2 (en) | Preparation for treating and preventing gastro-intestinal diseases in cattle youngsters | |
| JPH08337529A (en) | Therapeutic agent for disease in superior digestive tract | |
| ES8407057A1 (en) | Cephalosporin antibiotics. | |
| JPS6169723A (en) | Fungicidal medicinal composition | |
| JPS56103114A (en) | Drug for osteoporosis comprising 24r- hydroxycholecalciferol | |
| TOBRAMYCIN | that uf the trest existiq treatment is needed. FuIsTI~ T~~~~ aqmzkme of its use in the treatment of women and for rectal and pharyngeal gonorr | |
| KR890007737A (en) | Anti-caking agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970505 |